TCR2 Therapeutics Inc (NASDAQ:TCRR)

1.46
Delayed Data
As of 3:57pm ET
 +0.07 / +5.04%
Today’s Change
0.82
Today|||52-Week Range
3.88
+46.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

--
Operating ActivitiesNet Income / Starting Line-9.9M-13.1M-24.3M--
 
 
 
 
Depreciation220.0K298.0K419.0K--
 
 
 
 
Total Other Cash Flow93.0K408.0K1.9M--
 
 
 
 
Funds From Operations-9.6M-12.4M-22.0M--
 
 
 
 
Funds From/For Other Operating Expenses-222.0K-329.0K-3.2M--
 
 
 
 
Net Cash Flow - Operating Activities-9.4M-12.0M-18.8M--
 
 
 
 
 
InvestingIncrease In Investments-8.4M-6.8M-97.8M--
 
 
 
 
Decrease In Investments0.0014.8M22.5M--
 
 
 
Capital Expenditures-869.0K-388.0K-1.0M--
 
 
 
 
Net Cash Flow Investing-9.2M7.7M-76.3M--
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale22.5M16.2M123.0M--
 
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing22.5M16.2M123.0M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash3.9M11.8M27.9M--